These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 17139579)

  • 1. [HbA1c--the gold standard in the assessment of diabetes treatment?].
    Landgraf R
    Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S243-6. PubMed ID: 17139579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validity of random blood glucose as a predictor of the quality of glycaemic control by glycated haemoglobin in out-patient diabetic patients at Kenyatta National Hospital.
    Otieno FC; Ng'ang'a L; Kariuki M
    East Afr Med J; 2002 Sep; 79(9):491-5. PubMed ID: 12625691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Both the frequency of HbA
    Schwandt A; Best F; Biester T; Grünerbel A; Kopp F; Krakow D; Laimer M; Wagner C; Holl RW;
    Diabetes Metab Res Rev; 2017 Oct; 33(7):. PubMed ID: 28544457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond HbA1c.
    Bloomgarden Z
    J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline Glycated Hemoglobin Values Predict the Magnitude of Glycemic Improvement in Patients with Type 1 and Type 2 Diabetes: Subgroup Analyses from the DIAMOND Study Program.
    Billings LK; Parkin CG; Price D
    Diabetes Technol Ther; 2018 Aug; 20(8):561-565. PubMed ID: 30044123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinically significant disagreement between mean blood glucose and estimated average glucose in two populations: implications for diabetes management.
    Chalew SA; Hempe JM; McCarter R
    J Diabetes Sci Technol; 2009 Sep; 3(5):1128-35. PubMed ID: 20144426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time spent in target range assessed by self-monitoring blood glucose associates with glycated hemoglobin in insulin treated patients with diabetes.
    Cutruzzolà A; Irace C; Parise M; Fiorentino R; Pio Tripodi PF; Ungaro S; Babinsky V; Gnasso A
    Nutr Metab Cardiovasc Dis; 2020 Sep; 30(10):1800-1805. PubMed ID: 32669240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of metabolic control in patients with diabetes treated with insulin using Contour USB and A1cNow+ devices (COMET study).
    Vinagre I; Álvarez P; García N; Roura G; Conget I;
    Endocrinol Nutr; 2015 Oct; 62(8):384-90. PubMed ID: 26391507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of HbA1c and glucose variability in patients with type 1 and type 2 diabetes: outcome of continuous glucose monitoring (CGM).
    Sartore G; Chilelli NC; Burlina S; Di Stefano P; Piarulli F; Fedele D; Mosca A; Lapolla A
    Acta Diabetol; 2012 Dec; 49 Suppl 1():S153-60. PubMed ID: 22466072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translating glycated hemoglobin A1c into time spent in glucose target range: A multicenter study.
    Petersson J; Åkesson K; Sundberg F; Särnblad S
    Pediatr Diabetes; 2019 May; 20(3):339-344. PubMed ID: 30652407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.
    Vos FE; Schollum JB; Coulter CV; Manning PJ; Duffull SB; Walker RJ
    Nephrology (Carlton); 2012 Feb; 17(2):182-8. PubMed ID: 21883672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the relationship between glycated hemoglobin A1c and mean glucose levels derived from the professional continuous flash glucose monitoring system.
    Yamada M; Okada S; Oda H; Nakajima Y; C Bastie C; Kasai Y; Osaki A; Shimoda Y; Shibusawa R; Uehara R; Saito T; Ozawa A; Yamada E
    Endocr J; 2020 May; 67(5):531-536. PubMed ID: 32023560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycated haemoglobin; past, present, and future are we ready for the change.
    Syed IA
    J Pak Med Assoc; 2011 Apr; 61(4):383-8. PubMed ID: 21465979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-monitoring of blood glucose measurements and glycaemic control in a managed care paediatric type 1 diabetes practice.
    Davey B; Segal DG
    S Afr Med J; 2015 Apr; 105(5):405-7. PubMed ID: 26242666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of an mHealth-enabled hierarchical diabetes management intervention in primary care in China (ROADMAP): A cluster randomized trial.
    Jia W; Zhang P; Zhu D; Duolikun N; Li H; Bao Y; Li X;
    PLoS Med; 2021 Sep; 18(9):e1003754. PubMed ID: 34547030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Young patients with type 1 diabetes poorly controlled and poorly compliant with self-monitoring of blood glucose: can technology help? Results of the i-NewTrend randomized clinical trial.
    Di Bartolo P; Nicolucci A; Cherubini V; Iafusco D; Scardapane M; Rossi MC
    Acta Diabetol; 2017 Apr; 54(4):393-402. PubMed ID: 28138788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Reduced Self-Monitored Blood Glucose Testing After Adoption of Continuous Glucose Monitoring on Hemoglobin A1c and Time in Range.
    Puhr S; Calhoun P; Welsh JB; Walker TC
    Diabetes Technol Ther; 2018 Aug; 20(8):557-560. PubMed ID: 30036082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calculation of HbA1c and glycated albumin from serially measured self-monitored blood glucose in patients with type 1 diabetes mellitus.
    Koga M; Suzuki S; Matsuo K; Tanahashi Y; Azuma H; Kasayama S
    Clin Chim Acta; 2013 Oct; 425():188-91. PubMed ID: 23933122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
    Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
    Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials.
    Dicembrini I; Cosentino C; Monami M; Mannucci E; Pala L
    Acta Diabetol; 2021 Apr; 58(4):401-410. PubMed ID: 32789691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.